CN1352974A - Nerve receptor excitomotor - Google Patents

Nerve receptor excitomotor Download PDF

Info

Publication number
CN1352974A
CN1352974A CN 00133435 CN00133435A CN1352974A CN 1352974 A CN1352974 A CN 1352974A CN 00133435 CN00133435 CN 00133435 CN 00133435 A CN00133435 A CN 00133435A CN 1352974 A CN1352974 A CN 1352974A
Authority
CN
China
Prior art keywords
nerve receptor
nerve
part radix
excitomotor
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 00133435
Other languages
Chinese (zh)
Inventor
孙中原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST OF LONG LIFE SHUNYI DISTRICT BEIJING
Original Assignee
INST OF LONG LIFE SHUNYI DISTRICT BEIJING
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST OF LONG LIFE SHUNYI DISTRICT BEIJING filed Critical INST OF LONG LIFE SHUNYI DISTRICT BEIJING
Priority to CN 00133435 priority Critical patent/CN1352974A/en
Publication of CN1352974A publication Critical patent/CN1352974A/en
Pending legal-status Critical Current

Links

Abstract

A nerve receptor excitant for treating infantile cerebroplegia, brain injury sequela and lumbar intervertebral disk protrusion by exciting human factors is prepared from 9 Chinese medicinal materials including lycopodium, Chinese angelica root, red peony root, astragalus root, red sage root, etc.. Its advantages include high curative effect, quickly taking its effect, low cost and little by-effect.

Description

Nerve receptor excitomotor
The present invention relates to a kind of medicine for external use for the treatment of function of nervous system, particularly nerve receptor excitomotor.
The problem of neuroreceptor aspect is that many in the world medical experts and scholars want the difficult medical problem of capturing.Existing neurological disease such as cerebral palsy, cerebral trauma sequela, prolapse of lumbar intervertebral disc, rheumatoid etc.Disease is more thorny on existing traditional therapy medically at present, and for example children's's cerebral palsy makes to occur central paralysis in the infancy stage, can be unusual with mental retardation, convulsions, epilepsy, dystropy, disturbance of perception and other.At present above-mentioned disease is not still had effective Therapeutic Method, on medical literature, also do not have the record of Therapeutic Method.Prolapse of lumbar intervertebral disc and for example, general just massage treatment is to alleviate the state of an illness at that time, but the state of an illness there is not benefit from long-range, have both allow to the treatment, cost that patient spent and risk are all than higher, can treat by performing the operation as prolapse of lumbar intervertebral disc, but the treatment difficulty is that very large therapeutic process is also very painful, cure rate is lower, in addition, general treatment all is to utilize external factor to cure the disease, as has an injection, massages, takes medicine, but have an injection, taking medicine has side effect to human body.
The purpose of this invention is to provide a kind of medicine for external use for the treatment of function of nervous system is nerve receptor excitomotor, receptor refers generally to some the special part on postsynaptic membrane or the effector lymphocyte, its chemical nature belongs to protein, some drugs both can with receptors bind, can excite the function of receptor again, be called receptor stimulating agent.The difficulty that it exists in the time of solving the above-mentioned disease of treatment, it can utilize the human body self factor to cure the disease, from human external with efficacy of a drug osmosis to the inside of human body site of disease, it is enhanced vigour the human body factor excitement of site of disease, low, the instant effect of its treatment difficulty, treatment cost is low, and patient is subjected to or suffer not less during treatment, and the treatment risk is little.
The objective of the invention is to realize by following technical scheme.
Nerve receptor excitomotor of the present invention is made of by weight proportion following component:
Lycopodium clavatum 20-26 part Radix Angelicae Sinensis 22-26 part Radix Paeoniae Rubra 22-26 part
Radix Astragali 22-26 part Herba speranskiae tuberculatae 22-26 part Radix Clematidis 22-26 part
Radix Salviae Miltiorrhizae 20-26 part Radix Polygoni Multiflori 8-14 part nicotine 0.020-0.03 part
In said components, with Lycopodium clavatum, nicotine is key component, be equipped with other component for auxiliary, wherein the main component of Lycopodium clavatum is a choline, and effect is to make the neurotransmitter excitement, the material of transmission, nicotine produces excitation to the neuroreceptor of the neural joint of skeletal muscle, promotes the transmission of impulsion, Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, has promoting blood circulation to remove blood stasis regulating menstruation blood and acts on bitterly, the Radix Astragali, Radix Polygoni Multiflori have QI invigorating invigorating the liver and kidney effect, and Radix Clematidis, Herba speranskiae tuberculatae have the effect of the removing dampness of dispeling the wind dredge the meridian passage.The present invention spreads on the illing skin outside outward with each set of dispense integrator, and by the drug osmotic effect, the messenger drug masterpiece is used the affected part.Mainly act on preceding fiber of sympathetic nerve and parasympathetic ganglion and skeletal muscle movement nerve, it both can discharge acetylcholine by excited parasympathetic nervous, also can exciting sympathetic nerves discharge norepinephrine.The receptor acting of this agonist and disease sites, make the calcium channel that links with receptor open, cause calcium ion to enter in the cell, cause that cell discharges multiple neurotransmitter, the performance physiological effect, cell activity enhancing, the irritability of raising human nerve, muscle, the function of each organ of raising human body, thereby raising organism ability, and promote diseased cells to recover homergy, and reparative regeneration, thus reach the effect of curing the disease.
This therapy is by percutaneous drug delivery, safety, reliable, no pain, is easy to grasp, and patient part is had stronger affinity interaction.
The method for production of agonist of the present invention is:
1, gets the raw materials ready.Nicotine is got ready, other each raw material is screened, remove impurity, by prescription
The regulation share is got ready.
2, water is carried.With in the raw material except that nicotine, be added in the water by prescription requirements, press decocting method decoction
Three times, boil the back at every turn and kept 30 minutes, the elimination slag concentrates medicinal liquid and sinks to the bottom.
3, freezing, concentrated solution is freezing, and then, pour out supernatant with 2/3 thawing of freezing liquid top
And adding nicotine, stir, be required medicinal liquid.
4, fill.With medicinal liquid bottling sealing, the autoclave sterilization sterilization medicament that gets product.This medicament makes
Time spent smears it on the affected part surface skin, passes through percutaneous drug delivery.
In sum, the present invention adopts nicotine, Lycopodium clavatum and other blood circulation promoting and blood stasis dispelling, wind-expelling pain-stopping, invigorating the liver and kidney medicine to be mixed with can reach therapeutic purposes to the human nerve receptor activation, and its treatment is simple and convenient, expense is low, and patient is painful few, and risk is little.The present invention mainly produces following effect clinically: make nerve, skeletal muscle, smooth muscle excitement, glandular secretion increases, and myocardial contraction, little vasoconstriction power are strengthened.Can treat spastic cerebral palsy, mental retardation, cerebral trauma sequela, nervous vascular Headache, neurosis, prolapse of lumbar intervertebral disc, femur head necrosis, various nerves, muscle disease etc.
Specifically introduce the present invention with embodiment below.
The present invention was the clinical use of preparation name with the cerebral palsy liniment once, and the treatment children cerebral palsy is respond well.
Embodiment:
One, prescription
Lycopodium clavatum 2.4kg Radix Angelicae Sinensis 2.3kg Radix Paeoniae Rubra 2.3kg
Radix Astragali 2.5kg Herba speranskiae tuberculatae 2.6kg Radix Clematidis 2.6kg
Radix Salviae Miltiorrhizae 2.6kg Radix Polygoni Multiflori 1kg nicotine 2.3g
Two, method for production:
1, gets the raw materials ready.By prescription nicotine is got ready, with other each component raw material screening, clean, removal
Impurity.
2, water is carried.In each component of raw material, remove other outer component of nicotine also with 25kg water logging bubble
Boil three times, kept 30 minutes at every turn, the elimination slag concentrates medicinal liquid, precipitate.
3, freezing, concentrated solution is freezing, then freezing liquid top 2/3 is melted, pour out supernatant,
Add nicotine in containing 0.25 milligram of nicotine ratio in every milliliter of supernatant, stir, promptly
Be required liquid preparation.
4, fill.With liquid preparation bottling sealing, the autoclave sterilization sterilization medicament that gets product.
Medicament of the present invention is through animal experiment, and conclusion is: smearing nerve receptor excitomotor of the present invention at mouse skin, is maximum dose level 60ml/kg, observes 7 days, and no dead mouse is so its LD50 affirms that this dosage is higher 120 times than clinical consumption 0.5ml/kg greater than 60ml/kg.
Nerve fires agent of the present invention was once accepted CP children 238 examples, total effective rate 98.55%, obvious effective rate 64.25%, effective percentage 34.3% with preparation cerebral palsy liniment by name for medical treatment in Beijing and Shijiazhuang altogether.Illustrate that nerve receptor excitomotor of the present invention is that clinical effectiveness is better, and is especially more remarkable to spasm type patient treatment effect at a kind of new medicine of treatment cerebral palsy pathomechanism.Nerve fires agent of the present invention also can be treated diseases such as cerebral trauma sequela, nervous headache, prolapse of lumbar intervertebral disc, femur head necrosis, rheumatoid, soft tissue injury according to its treatment pathology, now just studies in the enforcement.

Claims (3)

1, nerve receptor excitomotor is characterized in that: it is made of by weight proportion following component:
Lycopodium clavatum 20-26 part Radix Angelicae Sinensis 22-26 part Radix Paeoniae Rubra 22-26 part
Radix Astragali 22-26 part Herba speranskiae tuberculatae 22-26 part Radix Clematidis 22-26 part
Radix Salviae Miltiorrhizae 20-26 part Radix Polygoni Multiflori 8-14 part nicotine 0.020-0.03 part
2, nerve receptor excitomotor according to claim 1 is characterized in that: described nerve receptor excitomotor is a water preparation.
3, nerve receptor excitomotor according to claim 2 is characterized in that: described nerve receptor excitomotor is used for the treatment of children cerebral palsy disease through skin external application administration.
CN 00133435 2000-11-06 2000-11-06 Nerve receptor excitomotor Pending CN1352974A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 00133435 CN1352974A (en) 2000-11-06 2000-11-06 Nerve receptor excitomotor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 00133435 CN1352974A (en) 2000-11-06 2000-11-06 Nerve receptor excitomotor

Publications (1)

Publication Number Publication Date
CN1352974A true CN1352974A (en) 2002-06-12

Family

ID=4595714

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 00133435 Pending CN1352974A (en) 2000-11-06 2000-11-06 Nerve receptor excitomotor

Country Status (1)

Country Link
CN (1) CN1352974A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1889906B (en) * 2003-12-10 2010-12-01 金伯利-克拉克环球有限公司 Interlabial absorbent article with improved flushability characteristics
CN108567855A (en) * 2018-07-09 2018-09-25 张春枝 Treat the Chinese medicine of brain paralysis
CN111317769A (en) * 2020-04-20 2020-06-23 鲁南制药集团股份有限公司 Application of traditional Chinese medicine composition in treatment of postoperative complications of arthroscopic surgery

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1889906B (en) * 2003-12-10 2010-12-01 金伯利-克拉克环球有限公司 Interlabial absorbent article with improved flushability characteristics
CN108567855A (en) * 2018-07-09 2018-09-25 张春枝 Treat the Chinese medicine of brain paralysis
CN111317769A (en) * 2020-04-20 2020-06-23 鲁南制药集团股份有限公司 Application of traditional Chinese medicine composition in treatment of postoperative complications of arthroscopic surgery

Similar Documents

Publication Publication Date Title
CN1861187A (en) Medicated wine for treating rheumatosis and osteoarthropathy
CN1291745C (en) Chinese medicinal composition for diseases of nervus, varscular headache, cerebral blood supply lack and sequel of apolexy
CN1051237C (en) Meicinal prepn. "Kexianling" for curing epilepsy
CN1539447A (en) Medicated rehabilitation wine for treating premonitory apoplexy, sequela of apoplexy and obastrcution of qi in chest
CN1927240A (en) Traditional Chinese medicine mask composition for depigmenting
CN1876034A (en) An externally applied analgetic and preparation method thereof
CN1352974A (en) Nerve receptor excitomotor
CN1565524A (en) Medicine for treating senile dementia and its preparing process
CN1092968C (en) Pharmaceuticals for treating outer skin blood vessel diease in cold seasons
CN1377672A (en) Rheumatic pain killing preparation
CN1108809C (en) Medicine for treating leukoderma and preparing process thereof
CN1342479A (en) Quick-acting oral liquid for treating sprain and pull and its preparing process
CN1284579C (en) Oral medicine for treating ischemic necrosis of femoral head and its preparation
CN1122520C (en) Osteanaphysis capsule for treating femoral head necrosis
CN1178683C (en) Cerebral hemorrhage treating traditional Chinese medicine
CN1261153C (en) Drug addiction stopping medicine for opium medicine addict
CN1302639A (en) Tendon-conditioning analgetic
CN1682858A (en) Adhesive umbilicus powder for removing spot
CN1923230A (en) Medicine for treating rheumatism and rheumatoid disease, and its preparation method
CN1091382C (en) Compound Lingxian headache-treating capsule and its preparation
CN1216623C (en) Blood pressure reducing and stabiliaing Chinese medicine and its prepn
CN1846739A (en) Hemiplegia treating Chinese medicine composition and its prepn process
CN100350964C (en) Medicine for treating femoral head necrosis and its preparation method
CN105560537A (en) Medicine composition for treating osteoartritis and preparation method thereof
CN1174714A (en) Whole set prescription for rehabilitation of hemiplegia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication